178 related articles for article (PubMed ID: 35641533)
1. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
3. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
4. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
5. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
[No Abstract] [Full Text] [Related]
6. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
7. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
8. Glucagonoma syndrome associated with necrolytic migratory erythema.
Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
[TBL] [Abstract][Full Text] [Related]
9. Glucagonoma syndrome with severe erythematous rash: A rare case report.
Wang ZX; Wang F; Zhao JG
Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
[TBL] [Abstract][Full Text] [Related]
10. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
Wu SL; Bai JG; Xu J; Ma QY; Wu Z
World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
[TBL] [Abstract][Full Text] [Related]
11. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
12. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
[No Abstract] [Full Text] [Related]
13. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract][Full Text] [Related]
15. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
[No Abstract] [Full Text] [Related]
16. Glucagonoma syndrome with atypical necrolytic migratory erythema.
He S; Zeng W; Geng S; Jia J
Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
[TBL] [Abstract][Full Text] [Related]
17. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
Boujan N; Géraud C
Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
[No Abstract] [Full Text] [Related]
19. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
[TBL] [Abstract][Full Text] [Related]
20. Necrolytic migratory erythema and pancreatic glucagonoma.
Rodríguez G; Vargas E; Abaúnza C; Cáceres S
Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
